Theravitae,
a biotechnology company working in adult stem cell research, was recently awarded the title
“Biotechnology Company of the Year” for its innovative work in regenerative
heart medicine. Despite what the mainstream news media would have us
believe, adult stem cell research offers the most promise for successful
regenerative therapies.
At the
award ceremony the President of Therivitae offered these important words:
"We are honored to be a recipient of this prestigious
award and we carry the responsibility to further help the progress of
discoveries within the regenerative medicine field. Our industry is on the
verge of redefining conventional healthcare through the miracles of adult stem
cells and their remarkable ability to facilitate the regeneration of personal
health. Despite the constant questionable claims of those in the embryonic
lobby, it is adult stem cells which will be the first to successfully treat
diabetes, Parkinson's and Alzheimers - embryonic stem cell therapies lag not by
months, but by years, if not decades!"
For more
information on the exciting developments in ethical adult stem cell research click here.